Ledger.Open graph →
SEC Form D · filed June 24, 2015

Apex Therapeutics, Inc

Offering
$650K
Sold
$275K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
INDIANAPOLIS, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Martin R. Haslanger, Phd · Indianapolis, INDirectorMark R. Kelly, Phd · Indianapolis, INExec · DirectorRoger R. Miller · Indianapolis, INExecHomer R. Pearce · Indianapolis, INDirectorDavid R. Broecker · Indianapolis, INExec · DirectorJohn R. Barnard · Indianapolis, INDirectorBrian Anderson · Birmingham, ALExec · DirectorHasan Ansari · New Haven, CTDirectorCharles F. Gillies · Woburn, MAExec · DirectorRichard R. Messman, Md · Indianapolis, INExecYulia Khvan · New Haven, CTExec · DirectorFanni Li · New Haven, CTExec · DirectorSrikar Prasad · New Haven, CTExec · DirectorKrish Panu · ALAMEDA, CADirectorKenny Lin · Las Vegas, NVDirectorMerav Resistal · Greenwich, CTExecRichard R. Messman, Md · Indianapolis, INExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗